Related by context. Frequent words. (Click for all words.) 70 Phase III randomized 69 Phase 2a trial 67 Phase 2b study 67 Phase 2a clinical 67 Phase 2b trial 67 Phase 1b 67 multicenter randomized double 66 Phase Ib 66 dose escalation trial 64 Phase IIa clinical 64 Phase 1b trial 64 Phase 2b clinical 64 Phase 1b clinical 64 Phase 2a 63 phase IIb 63 phase IIa 63 randomized placebo controlled 63 Phase IIb 63 Phase 1a 62 confirmatory Phase III 62 Phase IIa trial 62 dose cohorts 62 pivotal Phase 62 Phase III pivotal 62 label dose escalation 61 phase 2a 61 dose escalation study 61 Phase IIb clinical 61 randomized Phase III 61 randomized Phase 61 dose escalation 61 Phase IIb trial 60 multicenter clinical 60 randomized double 60 Phase IIa 60 unblinded 60 safety tolerability pharmacokinetics 60 Phase 2b 60 blinded placebo controlled 59 pivotal Phase III 59 placebo controlled 59 Phase Ia 59 multiple ascending dose 59 prospective randomized 59 Phase III 59 Phase III clinical 58 randomized #:# 58 multicentre 58 HGS ETR1 58 CA4P 58 blind randomized placebo 58 multicenter 57 safety tolerability 57 confirmatory Phase 3 57 blind randomized 57 pharmacodynamics 57 randomized controlled 56 RG# [001] 56 double blind placebo 56 Phase II 56 evaluable patients 56 single ascending dose 56 axitinib 56 TELCYTA 56 elagolix 55 PEG Interferon lambda 55 BAY #-# 55 pharmacokinetic 55 clinical trial 54 PROMACTA 54 ofatumumab 54 dose regimens 54 subgroup analyzes 54 PROPEL trial 54 PXD# 54 randomized 54 Investigational Device Exemption IDE 54 nitazoxanide 54 DURATION 54 non inferiority 54 TG# [001] 53 PROPEL 53 GVAX 53 sapacitabine 53 pharmacokinetic studies 53 GVAX immunotherapy 53 randomized controlled clinical 53 vicriviroc 53 prespecified 53 tolerated dose MTD 53 ZYBRESTAT 53 PS# [001] 52 Phase III trials 52 tesmilifene 52 tolerability 52 blind placebo controlled 52 plus prednisone 52 AP# [003] 52 dose limiting toxicities 52 randomized clinical 52 noninferiority